Literature DB >> 8561782

Cloning and sequence analysis of the cDNA for a protein from Coccidioides immitis with immunogenic potential.

K O Dugger1, K M Villareal, A Ngyuen, C R Zimmermann, J H Law, J N Galgiani.   

Abstract

We have cloned and sequenced the cDNA encoding an immunoreactive protein from the pathogenic fungus Coccidioides immitis which stimulates human T cells and has been associated with protective vaccines in mice. The transcript contained an open reading frame encoding 194 amino acids with a calculated molecular weight of 19.5 kDa, a 151 base 5' untranslated region (UTR), and a 468 base 3'UTR. A four member repeat motif, usually thr-ala-glu-pro, exists for amino acids 98 through 141. Deduced amino acid sequence derived from the cDNA was identical with previously determined internal amino acid sequence from the native protein, and goat antiserum raised against the purified fungal protein reacted with an inducible fusion protein translated from this cDNA. Using this cDNA to produce recombinant protein will allow direct testing of its role in human immunity to coccidioidomycosis and may lead to new diagnostic tests.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8561782     DOI: 10.1006/bbrc.1996.0086

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

1.  Coadministration of interleukin 12 expression vector with antigen 2 cDNA enhances induction of protective immunity against Coccidioides immitis.

Authors:  C Jiang; D M Magee; R A Cox
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

Review 2.  Measurement of cellular immunity in human coccidioidomycosis.

Authors:  Neil M Ampel
Journal:  Mycopathologia       Date:  2003       Impact factor: 2.574

3.  Evaluation of the proline-rich antigen of Coccidioides immitis as a vaccine candidate in mice.

Authors:  T N Kirkland; F Finley; K I Orsborn; J N Galgiani
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

4.  Genetic vaccination against Coccidioides immitis: comparison of vaccine efficacy of recombinant antigen 2 and antigen 2 cDNA.

Authors:  C Jiang; D M Magee; T N Quitugua; R A Cox
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

5.  Molecular cloning and characterization of Coccidioides immitis antigen 2 cDNA.

Authors:  Y Zhu; C Yang; D M Magee; R A Cox
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

6.  Transcriptome analysis of Paracoccidioides brasiliensis cells undergoing mycelium-to-yeast transition.

Authors:  Luiz R Nunes; Regina Costa de Oliveira; Daniela Batista Leite; Vivian Schmidt da Silva; Everaldo dos Reis Marques; Márcia Eliana da Silva Ferreira; Diógenes Custódio Duarte Ribeiro; Luciano Angelo de Souza Bernardes; Maria Helena S Goldman; Rosana Puccia; Luiz R Travassos; Wagner L Batista; Marina Pasetto Nóbrega; Francisco G Nobrega; Ding-Yah Yang; Carlos A de Bragança Pereira; Gustavo H Goldman
Journal:  Eukaryot Cell       Date:  2005-12

Review 7.  Coccidioidomycosis: host response and vaccine development.

Authors:  Rebecca A Cox; D Mitchell Magee
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

8.  Evaluation of two homologous proline-rich proteins of Coccidioides posadasii as candidate vaccines against coccidioidomycosis.

Authors:  Roger A Herr; Chiung-Yu Hung; Garry T Cole
Journal:  Infect Immun       Date:  2007-09-17       Impact factor: 3.441

9.  Vaccine-induced cellular immune responses differ from innate responses in susceptible and resistant strains of mice infected with Coccidioides posadasii.

Authors:  Lisa F Shubitz; Sharon M Dial; Robert Perrill; Rachael Casement; John N Galgiani
Journal:  Infect Immun       Date:  2008-10-13       Impact factor: 3.441

10.  Protein expression profiling of Coccidioides posadasii by two-dimensional differential in-gel electrophoresis and evaluation of a newly recognized peroxisomal matrix protein as a recombinant vaccine candidate.

Authors:  Kris I Orsborn; Lisa F Shubitz; Tao Peng; Ellen M Kellner; Marc J Orbach; Paul A Haynes; John N Galgiani
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.